» Articles » PMID: 37117532

Induced Volatolomics of Pathologies

Overview
Journal Nat Rev Chem
Publisher Springer Nature
Specialty Chemistry
Date 2023 Apr 28
PMID 37117532
Authors
Affiliations
Soon will be listed here.
Abstract

Volatolomics allows us to elucidate cell metabolic processes in real time. In particular, a volatile organic compound (VOC) excreted from our bodies may be specific for a certain disease, such that measuring this VOC may afford a simple, fast, accessible and safe diagnostic approach. Yet, finding the optimal endogenous volatile marker specific to a pathology is non-trivial because of interlaboratory disparities in sample preparation and analysis, as well as high interindividual variability. These limit the sensitivity and specificity of volatolomics and its applications in biological and clinical fields but have motivated the development of induced volatolomics. This approach aims to overcome issues by measuring VOCs that result not from an endogenous metabolite but, rather, from the pathogen-specific or metabolic-specific enzymatic metabolism of an exogenous biological or chemical probe. In this Review, we introduce volatile-compound-based probes and discuss how they can be exploited to detect and discriminate pathogenic infections, to assess organ function and to diagnose and monitor cancers in real time. We focus on cases in which labelled probes have informed us about metabolic processes and consider the potential and drawbacks of the probes for clinical trials. Beyond diagnostics, VOC-based probes may also be effective tools to explore biological processes more generally.

Citing Articles

Evaluation of urinary volatile organic compounds as a novel metabolomic biomarker to assess chronic kidney disease progression.

Wu H, Possell M, Nguyen L, Peng W, Pollock C, Saad S BMC Nephrol. 2024; 25(1):352.

PMID: 39407183 PMC: 11476779. DOI: 10.1186/s12882-024-03819-0.


Induced-volatolomics for the design of tumour activated therapy.

Chatre R, Blochouse E, Eid R, Djago F, Lange J, Tarighi M Chem Sci. 2023; 14(18):4697-4703.

PMID: 37181780 PMC: 10171039. DOI: 10.1039/d2sc06797h.


Identification of volatile biomarkers of Trichomonas vaginalis infection in vaginal discharge and urine.

Rubio-Sanchez R, Rios-Reina R, Ubeda C Appl Microbiol Biotechnol. 2023; 107(9):3057-3069.

PMID: 37000228 PMC: 10106345. DOI: 10.1007/s00253-023-12484-6.


The untargeted urine volatilome for biomedical applications: methodology and volatilome database.

Llambrich M, Brezmes J, Cumeras R Biol Proced Online. 2022; 24(1):20.

PMID: 36456991 PMC: 9714113. DOI: 10.1186/s12575-022-00184-w.


The factors that govern the allosteric chemical sensing of polythiophene chemosensors: scope and limitation toward signal-amplification sensing.

Tsuchiya T, Mizuno H, Fukuhara G RSC Adv. 2022; 11(48):30472-30478.

PMID: 35493992 PMC: 9041329. DOI: 10.1039/d1ra05795b.


References
1.
Bianconi E, Piovesan A, Facchin F, Beraudi A, Casadei R, Frabetti F . An estimation of the number of cells in the human body. Ann Hum Biol. 2013; 40(6):463-71. DOI: 10.3109/03014460.2013.807878. View

2.
Amann A, de Lacy Costello B, Miekisch W, Schubert J, Buszewski B, Pleil J . The human volatilome: volatile organic compounds (VOCs) in exhaled breath, skin emanations, urine, feces and saliva. J Breath Res. 2014; 8(3):034001. DOI: 10.1088/1752-7155/8/3/034001. View

3.
de Lacy Costello B, Amann A, Al-Kateb H, Flynn C, Filipiak W, Khalid T . A review of the volatiles from the healthy human body. J Breath Res. 2014; 8(1):014001. DOI: 10.1088/1752-7155/8/1/014001. View

4.
Broza Y, Zuri L, Haick H . Combined volatolomics for monitoring of human body chemistry. Sci Rep. 2014; 4:4611. PMC: 3980217. DOI: 10.1038/srep04611. View

5.
Angle C, Waggoner L, Ferrando A, Haney P, Passler T . Canine Detection of the Volatilome: A Review of Implications for Pathogen and Disease Detection. Front Vet Sci. 2016; 3:47. PMC: 4919317. DOI: 10.3389/fvets.2016.00047. View